131 related articles for article (PubMed ID: 17454849)
1. Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients.
Soska V; Ciz M; Kubala L; Sobotova D; Lojek A
Scand J Clin Lab Invest; 2007; 67(3):343-51. PubMed ID: 17454849
[TBL] [Abstract][Full Text] [Related]
2. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
3. Changes of antioxidative homeostasis in patients on chronic haemodialysis.
Schmidtmann S; Müller M; von Baehr R; Precht K
Nephrol Dial Transplant; 1991; 6 Suppl 3():71-4. PubMed ID: 1663603
[TBL] [Abstract][Full Text] [Related]
4. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
5. [Changes in anti-oxidative homeostasis in hemodialysis patients].
Schmidtmann S; Popov I; Precht K; von Baehr R
Z Urol Nephrol; 1989 Feb; 82(2):77-80. PubMed ID: 2728633
[TBL] [Abstract][Full Text] [Related]
6. Global assessment of serum antioxidant status in hemodialysis patients.
Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
9. [Oxidative stress in chronic renal failure and hemodialysis].
Descamps-Latscha B; Witko-Sarsat V
Nephrologie; 2003; 24(7):377-9. PubMed ID: 14650750
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
11. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
Clermont G; Lecour S; Lahet J; Siohan P; Vergely C; Chevet D; Rifle G; Rochette L
Cardiovasc Res; 2000 Aug; 47(3):618-23. PubMed ID: 10963735
[TBL] [Abstract][Full Text] [Related]
12. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients.
Antolini F; Valente F; Ricciardi D; Baroni M; Fagugli RM
Clin Chim Acta; 2005 Aug; 358(1-2):87-94. PubMed ID: 15885684
[TBL] [Abstract][Full Text] [Related]
13. Cardiac biomarkers and survival in haemodialysis patients.
Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oxidative/antioxidative status of penile corpus cavernosum blood and peripheral venous blood.
Yeni E; Gulum M; Selek S; Erel O; Unal D; Verit A; Savas M
Int J Impot Res; 2005; 17(1):19-22. PubMed ID: 15510194
[TBL] [Abstract][Full Text] [Related]
15. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
[TBL] [Abstract][Full Text] [Related]
16. Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients.
de Cavanagh EM; Honegger AE; Hofer E; Bordenave RH; Bullorsky EO; Chasseing NA; Fraga C
Cancer; 2002 Jun; 94(12):3247-51. PubMed ID: 12115357
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.
Bain MA; Faull R; Fornasini G; Milne RW; Evans AM
Nephrol Dial Transplant; 2006 May; 21(5):1300-4. PubMed ID: 16401621
[TBL] [Abstract][Full Text] [Related]
18. Repeated red wine consumption and changes on plasma antioxidant capacity and endogenous antioxidants (uric acid and protein thiol groups).
Otaolaurruchi E; Fernández-Pachón MS; Gonzalez AG; Troncoso AM; García-Parrilla MC
J Agric Food Chem; 2007 Nov; 55(23):9713-8. PubMed ID: 17941686
[TBL] [Abstract][Full Text] [Related]
19. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.
Reuter SE; Evans AM; Faull RJ; Chace DH; Fornasini G
Ann Clin Biochem; 2005 Sep; 42(Pt 5):387-93. PubMed ID: 16168195
[TBL] [Abstract][Full Text] [Related]
20. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
Van Campenhout A; Van Campenhout C; Lagrou A; Manuel-y-Keenoy B
Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
